Julie Horowitz's Colleagues at Paul Ellis Law Group
Julie Horowitz's Contact Details
N/A
New York, New York, United States
Paul Ellis Law Group
Julie Horowitz's Company Details
The attorneys of the Paul Ellis Law Group are committed to achieving three important objectives for our clients: providing the highest quality legal advice, aggressively representing their interests, and assisting them in fulfilling their goals as efficiently and cost-effectively as possible. Educated in the nation's finest universities and law schools and trained in major law firms, we are well-versed in the intricacies of sophisticated business law practice. We combine large-firm expertise with the personal attention and efficiencies that come with small-firm practice. Our ClientsOur client base and experience spans many industries, including information technology, new media, mobile, telecommunications, health care and life sciences, biotech, pharmaceuticals, manufacturing, banking and financial services, money transmission, real estate finance, consumer products and entertainment. We have significant cross-border experience, representing U.S.-based business in the international arena, as well as foreign businesses and individuals with their U.S. legal affairs.Our ServicesOur clients benefit from having access to a full range of fundamental legal disciplines within one firm. We have extensive expertise at all levels of business structuring and formation, debt and equity offerings, securities laws compliance, equity incentive plans, mergers and acquisitions and joint venture arrangements. In the area of intellectual property protection and commercialization, our attorneys handle sophisticated licensing and strategic partnering arrangements and general advising on best practices in IP protection contracting and procedures. In the dispute resolution arena, we regularly appear in state and federal court and arbitration forums on complex commercial matters and other types of disputes. We also have expertise in commercial real estate finance, bankruptcy and the development of drugs and regulated medical devices.